| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,199 |
10,442 |
$1.92M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,258 |
6,118 |
$919K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,372 |
1,627 |
$819K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,916 |
2,498 |
$451K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,155 |
4,127 |
$425K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,625 |
2,459 |
$422K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,180 |
1,027 |
$296K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,768 |
1,121 |
$259K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,097 |
948 |
$256K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
188 |
168 |
$240K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,895 |
1,462 |
$219K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,917 |
1,696 |
$154K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
896 |
724 |
$76K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
577 |
452 |
$63K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,695 |
1,487 |
$56K |
| 80053 |
Comprehensive metabolic panel |
7,847 |
6,200 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,196 |
1,016 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,051 |
7,509 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,509 |
1,665 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
592 |
486 |
$34K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
37 |
17 |
$31K |
| 80061 |
Lipid panel |
2,403 |
2,182 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
1,749 |
1,481 |
$27K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,855 |
1,628 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,291 |
741 |
$22K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
131 |
124 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
984 |
862 |
$22K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,554 |
2,859 |
$21K |
| 83880 |
|
1,508 |
1,223 |
$21K |
| 84484 |
|
3,849 |
2,427 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
311 |
252 |
$18K |
| 87634 |
|
432 |
365 |
$18K |
| 80050 |
General health panel |
977 |
856 |
$14K |
| 81025 |
|
1,668 |
1,408 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,267 |
1,107 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,256 |
3,413 |
$12K |
| 81001 |
|
5,620 |
4,646 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
92 |
75 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,428 |
1,308 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
94 |
82 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
162 |
151 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
282 |
226 |
$11K |
| 85610 |
|
2,628 |
1,746 |
$11K |
| 83605 |
|
2,124 |
1,623 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
393 |
350 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,562 |
1,378 |
$9K |
| 11721 |
|
298 |
257 |
$8K |
| 83690 |
|
1,795 |
1,484 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
24 |
$8K |
| 83735 |
|
2,547 |
1,752 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
45 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
34 |
27 |
$7K |
| 84145 |
|
707 |
560 |
$6K |
| 73630 |
|
285 |
223 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,521 |
1,899 |
$6K |
| 86140 |
|
1,715 |
1,388 |
$5K |
| 82728 |
|
459 |
407 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
14,366 |
10,297 |
$4K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
35 |
27 |
$4K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
66 |
48 |
$4K |
| 36592 |
|
1,990 |
1,621 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
33 |
26 |
$4K |
| 85027 |
|
817 |
721 |
$4K |
| 85379 |
|
783 |
668 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
2,285 |
1,860 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
16 |
14 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
82 |
77 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
14 |
$2K |
| 73562 |
|
105 |
89 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
27 |
24 |
$1K |
| 85730 |
|
613 |
505 |
$1K |
| 87186 |
|
225 |
188 |
$1K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
56 |
12 |
$1K |
| 87088 |
|
205 |
151 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26 |
26 |
$849.98 |
| 83550 |
|
114 |
111 |
$849.63 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
12 |
12 |
$848.85 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
25 |
$813.72 |
| 83540 |
|
140 |
135 |
$783.93 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
66 |
37 |
$763.12 |
| 87040 |
|
250 |
123 |
$749.89 |
| 83615 |
|
250 |
200 |
$724.40 |
| 82150 |
|
151 |
133 |
$670.36 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32 |
28 |
$624.58 |
| 84153 |
|
41 |
37 |
$581.71 |
| 73610 |
|
38 |
38 |
$532.40 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,029 |
1,512 |
$425.24 |
| 81003 |
|
206 |
156 |
$416.96 |
| 85652 |
|
216 |
190 |
$404.69 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13 |
13 |
$402.12 |
| 86803 |
|
28 |
26 |
$402.00 |
| 80306 |
|
29 |
26 |
$314.45 |
| 82550 |
|
134 |
109 |
$302.63 |
| 73030 |
|
15 |
13 |
$283.20 |
| 82570 |
|
70 |
65 |
$264.02 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,352 |
882 |
$234.01 |
| 82962 |
|
236 |
105 |
$188.70 |
| 86618 |
|
14 |
14 |
$176.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,976 |
1,661 |
$155.56 |
| 80305 |
|
14 |
12 |
$154.01 |
| 87077 |
|
45 |
36 |
$150.30 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14 |
12 |
$125.86 |
| 85018 |
|
61 |
56 |
$123.84 |
| 82043 |
|
29 |
28 |
$119.94 |
| 84439 |
|
16 |
16 |
$102.52 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
485 |
421 |
$83.93 |
| 87081 |
|
24 |
14 |
$82.00 |
| 82977 |
|
13 |
12 |
$76.17 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,309 |
1,667 |
$64.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,333 |
1,010 |
$61.18 |
| J2704 |
Injection, propofol, 10 mg |
519 |
386 |
$36.13 |
| J3490 |
Unclassified drugs |
161 |
109 |
$26.66 |
| 96376 |
|
190 |
154 |
$23.45 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
678 |
494 |
$3.58 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
609 |
468 |
$1.67 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
147 |
75 |
$0.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
585 |
416 |
$0.14 |
| A9270 |
Non-covered item or service |
796 |
578 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
259 |
211 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
13 |
$0.00 |